发明名称 |
Methods and products for treating proliferative diseases |
摘要 |
Methods and products for treating proliferative diseases, and wounds, using as a pharmacon an autophagy inhibitor, a glycolytic inhibitor, and/or an agent able to alter cellular production of reactive oxygen, or combination thereof, optionally in combination with one or more chemotherapeutic agents. In some embodiments, the invention combines a 4-aminoquinoline, exemplified by chloroquine, with a glycolytic inhibitor, exemplified by 2-deoxy-D-glucose and anti-VEGF antibodies. The systems and methods of the invention may be used to treat drug-resistant or multi-drug resistant cancers. |
申请公布号 |
US9073985(B2) |
申请公布日期 |
2015.07.07 |
申请号 |
US200913054147 |
申请日期 |
2009.07.14 |
申请人 |
The Regents of the University of Colorado, a body corporate |
发明人 |
Newell Martha Karen;Rogers Susannah K. |
分类号 |
C07K16/22;A61K31/4409;A61K31/7004;A61K39/395;A61K45/06;A61K31/4706;A61K39/00 |
主分类号 |
C07K16/22 |
代理机构 |
Wolf, Greenfield & Sacks, P.C. |
代理人 |
Wolf, Greenfield & Sacks, P.C. |
主权项 |
1. A method for treating cancer, comprising:
administering to a subject a therapeutically acceptable amount of an autophagy inhibitor and a VEGF receptor antagonist in an effective amount to treat the cancer, wherein the VEGF receptor antagonist is a small molecule inhibitor of a VEGFR tyrosine kinase and the autophagy inhibitor is chloroquine, and wherein the autophagy inhibitor and the VEGF receptor antagonist are administered sequentially. |
地址 |
Denver CO US |